Ascendis Pharma A (ASND) Income from Non-Controlling Interests (2017 - 2026)
Ascendis Pharma A's Income from Non-Controlling Interests came in at $246.22 million for the quarter ended Jun 30, 2026, compared with -$45.57 million a year earlier and down 66.7% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Income from Non-Controlling Interests (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ascendis Pharma A reported Income from Non-Controlling Interests of $873.82 million; for the year ended Dec 31, 2025, it came in at -$261.63 million.
- Going back by year, Income from Non-Controlling Interests was -$408.07 million in the year ended Dec 31, 2024, -$523.74 million in the year ended Dec 31, 2023, -$615.01 million in the year ended Dec 31, 2022 and -$434.39 million in the year ended Dec 31, 2021.
- The five-year range for quarterly Income from Non-Controlling Interests is -$209.36 million (the quarter ended Dec 31, 2022) to $740.38 million (the quarter ended Mar 31, 2026).
- Business Quant data shows ASND's Income from Non-Controlling Interests at $740.38 million (quarter ended Mar 31, 2026), -$39.64 million (quarter ended Dec 31, 2025) and -$73.14 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 246.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 246.22 Mn |
| Mar 31, 2026 | 740.38 Mn |
| Dec 31, 2025 | -39.64 Mn |
| Sep 30, 2025 | -73.14 Mn |
| Jun 30, 2025 | -45.57 Mn |
| Mar 31, 2025 | -99.61 Mn |
| Dec 31, 2024 | -40.22 Mn |
| Sep 30, 2024 | -108.77 Mn |
| Jun 30, 2024 | -117.77 Mn |
| Mar 31, 2024 | -142.28 Mn |
| Dec 31, 2023 | -95.09 Mn |
| Sep 30, 2023 | -175.97 Mn |
| Jun 30, 2023 | -133.34 Mn |
| Mar 31, 2023 | -119.89 Mn |
| Dec 31, 2022 | -209.36 Mn |
| Sep 30, 2022 | -172.58 Mn |
| Jun 30, 2022 | -87.58 Mn |
| Mar 31, 2022 | -140.37 Mn |
| Dec 31, 2021 | -120.10 Mn |
| Sep 30, 2021 | -93.56 Mn |
API Access
Ascendis Pharma A Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();